Log in
Enquire now
‌

US Patent 10071124 Treatment of post-traumatic stress disorder with isolated

Patent 10071124 was granted and assigned to Immodulon Therapeutics Limited on September, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
‌
Immodulon Therapeutics Limited
Current Assignee
‌
Immodulon Therapeutics Limited
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10071124
Date of Patent
September 11, 2018
Patent Application Number
14429697
Date Filed
September 17, 2013
Patent Primary Examiner
‌
Padmavathi Baskar
Patent abstract

The present invention relates to treatment or prevention of post-traumatic stress disorder (PTSD). In particular, the present invention relates to an isolated Mycobacterium, for use in the prevention of PTSD and the symptoms associated with such a disorder. Also provided are methods of improving resilience in a subject by administering a therapeutically effective amount of isolated Mycobacterium.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10071124 Treatment of post-traumatic stress disorder with isolated

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.